Journal Publications

From U of A

  1. I. Rubino, E. Oh, S. Han, S. Kaleem, A. Hornig, S.-H. Lee, H.-J. Kang, D.-H. Lee, K.-B. Chu, S. Kumaran, S. Armstrong, R. Lalani, S. Choudhry, C. I. Kim, F.-S. Quan, B. Jeon, and H.-J. Choi*, Scientific Reports, In press (2020), "Salt coatings functionalize inert membranes into high-performing filters against infectious respiratory diseases"

  2. B. Homayun, H. –J. Choi*, International Journal of Pharmaceutics, 579, 119152 (2020), "Halloysite nanotube-embedded microparticles for intestine-targeted co-delivery of biopharmaceuticals"

  3. D.-H. Lee, K.-B. Chu, H.-J.Kang, H.-W. Lee, M. Chopra, H.-J. Choi, E.-K. Moon, K.-S. Inn, F.-S. Quan, Malar J 18, 394 (2019), "Protection induced by malaria virus-like particles containing codon-optimized AMA-1 of Plasmodium berghei."

  4. H.-J. Kang, S.-H Lee, M.-J. Kim, K.-B. Chu, D.-H. Lee, M. Chopra H.-J. Choi, H. Park, H. Jin, F.-S. Quan, Pharmaceutics, 11(7), 342 (2019), "Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection"

  5. M.-C. Kim, K.-H. Kim, J. W. Lee, Y.-N. Lee, H.-J. Choi, Y.-J. Jung, Y.-J. Kim, R. W. Compans, M. R. Prausnitz, S.-M. Kang*, Pharmaceutics, 188 (2019), "Co-delivery of M2e virus-like particles with influenza split vaccine to the skin using microneedles enhances the efficacy of cross protection"

  6. B. Homayun, X. Lin, H.-J. Choi*, Pharmaceutics, 11, 129 (2019) "Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals" 

  7. K.-H. Kim, Y.-M. Kwon, Y.-T. Lee, M.-C. Kim, H. Hwang, E.-J. Ko, Y. Lee, H.-J. Choi, S.-M. Kang*, Vaccines, 6, 66 (2018), "Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus" 

  8. B. Homayun, A. Kumar, P.T.H. Nascimento, H. –J. Choi*, Archives of Pharmacal Research, 41(8), 848-860 (2018), "Macropored microparticles with a core-shell architecture for oral delivery of biopharmaceuticals"

  9. B. Homayun, C. Sun, A. Kumar, C. Montemagno*, H. –J. Choi*, European Journal of Pharmaceutics and Biopharmaceutics 128, 316–326 (2018), "Facile fabrication of microparticles with pH-responsive macropores for small intestine targeted drug formulation" Eudragit Award

  10. E. Oh, J. Bae, A. Kumar, H.-J. Choi, B. Jeon*, International Journal of Antimicrobial Agents (2018),  10.1016/j.ijantimicag.2018.03.006, "Antioxidant-based synergistic eradication of methicillin-resistant Staphylococcus aureus (MRSA) biofilms with bacitracin"

  11. A.-R. Kim, D.-H. Lee, S.-H. Lee, I. Rubino, H. –J. Choi, F.-S. Quan*, PLoS One 13(1): e0191277 (2018), "Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein"

  12. M.-C. Kim, Y.-N. Lee, Y.-J. Kim, H.–J. Choi, K.-H. Kim, Y.-J. Lee, S.-M. Kang*, Antiviral Research, 148, 43 (2017), "Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate"

  13. W.H. Choi, H. –J. Choi, T.W. Goo, F.-S. Quan*, Entomological Research, DOI: 10.1111/1748-5967.12259 (2017), "Novel antibacterial peptides induced by probiotics in Hermetia illucens (Diptera: Stratiomyidae) larvae"

  14. I. Rubino, H. –J. Choi*, Trends in Biotechnology, 35(10), 907 (2017), "Respiratory Protection against Pandemic and Epidemic Diseases"

  15. A. Kumar, C.D. Montemagno*, H. –J. Choi*, Scientific Reports, 7: 3059 (2017), "Smart Microparticles with a pH-responsive Macropore for Targeted Oral Drug Delivery"

  16. S.-H. Lee, A.-R. Kim, D.-H. Lee, I. Rubino, H. –J. Choi, F. S. Quan*, PLoS One 12(4), e0175644 (2017), "Protection induced by virus-like particles containing Toxoplasma gondii microneme protein 8 against highly virulent RH strain of Toxoplasma gondii infection"

  17. F.-S. Quan, I. Rubino, S.H. Lee, B. Koch, H. –J. Choi*, Scientific Reports, 7: 39956 (2017) "Universal and reusable virus deactivation system for respiratory protection"

  18. B. Koch, I. Rubino, F.-S. Quan, B. Yoo, H. –J. Choi*, Materials, 9(8), 646 (2016) "Microfabrication for Drug Delivery"

  19. J. Kim, I. Rubino, J.-Y. Lee, H. J. Choi*, Materials Research Express 3, 045019 (2016) "Application of Halloysite Nanotubes for Carbon Dioxide Capture"

  20. Y.C. Kim, S.H. Lee, W.H. Choi, H. J. Choi, T.W. Goo, J.H. Lee, F.S. Quan*, Journal of drug targeting, DOI:10.3109/1061186X.2016.1159213 (2016) "Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection"

  21. H. –J. Choi, J. –M. Song, B. J. Bondy, R. W. Compans, S. –M. Kang, M. Prausnitz, PLoS One 10(7), e0134431 (2015) "Effect of osmotic pressure on the stability of whole inactivated influenza vaccine for coating on microneedles"

  22. M. –C. Kim, J. –W. Lee, H. –J. Choi, Y. –N. Lee, H. S. Hwang, J. Lee, C. Kim, J. S. Lee, C. Montemagno, M. R. Prausnitz, S. –M. Kang, Journal of Controlled Release 210, 208-216 (2015) "Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtic cross-protection"

  23. J. Patel, M. –C. Kim, V. F. Vartabediana, Y. –N. Lee, S. He, J. –M. Song, H. –J. Choi, S. Yamanaka, N. Amarama, A. Lukachera, C. Montemagno, R. W. Compans, S. –M. Kang, P. Selvaraja, Nanomedicine 11(5), 1097-1107 (2015) "Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responses"

2014 and earlier

  1. H. –J. Choi*, M. –C. Kim, S. –M. Kang, C. D. Montemagno*, Archives of Pharmacal Research 37(12), 1607-1616 (2014) “The osmotic stress response of split influenza vaccine particles in an acidic environment”

  2. H. –J. Choi*, C. D. Montemagno*, Materials 6(12), 5821-5856 (2013) “Recent progress in advanced nanobiological materials for energy and environmental applications” 

  3. H. –J. Choi*, T. J. Stazak, C. D. Montemagno*, Journal of Nanoparticle Research 15(10), 1-13 (2013) “Surface-dependent cytotoxicity on bacteria as a model for environmental stress of halloysite nanotubes”

  4. H. –J. Choi*, C. Ebersbacher, M. –C. Kim, S. –M. Kang, C. D. Montemagno*, PLoS One 8(6), e66316 (2013) “A mechanistic study on the destabilization of whole inactivated influenza virus vaccine in gastric environment” Highlighted as  a key scientific article of Global Medical Discovery (June 28, 2013) 

  5. H. –J. Choi*, C. Ebersbacher, F. S. Quan, C. D. Montemango*, Nanotechnology 24(5), 055603 (2013) “pH stability and comparative evaluation of ranaspumin-2 foam for application in biochemical reactors” Feature cover article / a key scientific article in June 2013 issue of Global Medical Discovery 

  6. H. –J. Choi, B. Bondy, D. –G. Yoo, R. W. Compans, S. –M. Kang, M. R. Prausnitz, Journal of Controlled Release 166(2), 159-171 (2013). “Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles”

  7. H. –J. Choi*, C. Ebersbacher, N. V. Myung, C. D. Montemagno*, Journal of Nanoparticle Research 14(9), 1092:1-13 (2012) “Synthesis of nanoparticles with frog foam nest proteins”

  8. H. –J. Choi, D. –G. Yoo, B. Bondy, F. –S. Quan, R. W. Compans, S. –M. Kang, M. R. Prausnitz, Biomaterials 33(14), 3756-3769 (2012) “Stability of influenza vaccine coated onto microneedles”

  9. H. –J. Choi, D. Wendell, C. D. Montemagno, NanoBiotechnology 3(2), 66-75 (2007) “Advances in nano biotic/abiotic hybrid systems: Protein-based engineered devices”

  10. H. –J. Choi, C. D. Montemagno, IEEE Trans. on Nanotechnology 6(2), 171-176 (2007) “Light-driven hybrid bioreactor based on protein-incorporated polymer vesicles"

  11. H. –J. Choi, C. D. Montemagno, Nanotechnology 17, 2198-2202 (2006) “Biosynthesis within a bubble architecture”   

  12. H. –J. Choi, J. Germain, C. D. Montemagno, Nanotechnology 17, 1825-1830 (2006) “Effect of different reconstitution procedures on membrane protein activities in proteopolymersomes” 

  13. H. –J. Choi, C. D. Montemagno, Nano Letters 5, 2538-2542 (2005) “Artificial organelle: ATP synthesis from cellular mimetic polymersomes”  

  14. H. –J. Choi, H. Lee, C. D. Montemagno, Nanotechnology 16, 1589-1697 (2005) “Toward hybrid proteo-polymeric vesicles generating a photo-induced proton gradient for biofuel cells” 

  15. H. –J. Choi, E. Brooks, C. D. Montemagno, Nanotechnology 16, S143-149 (2005) “Synthesis and characterization of nanoscale biomimetic polymer vesicles and polymer membranes for bioelectronic applications”  

  16. M. –J. Kim, H. –J. Choi, D. –H. Ko, J. –H. Ku, S. Choi, K. Fujihara, C. –W. Yang, Electrochemical and Solid State Letters 6(10), G122-125 (2003) “High thermal stability of Ni monosilicide from Ni-Ta alloy films on Si(100)”

  17. S. –W. Nam, J. –H. Yoo, S. Nam, H. –J. Choi, D. Lee, D. –H. Ko, J. H. Moon, J. –H. Ku, S. Choi, Journal of Non-Crystalline Solids 303, 139-143 (2002) “Influence of annealing condition on the properties of sputtered hafnium oxide” 

  18. M. –J. Kim, H. –J. Choi, D. –H. Ko, J. –H. Ku, S. Choi, K. Fujihara, C. –W. Yang, Journal of the Korean Physical Society 40(4), 737-741 (2002) “Formation and thermal stability of Ti-capped Co-silicide from Co-Ta alloy films on (100) Si and polycrystalline silicon”   

Book Chapter


  1. H. –J. Choi*, C. D. Montemagno*, “Nanobiotechnology: transforming ideas to reality” Handbook of Science and Technology Convergence: Convergence of Nanotechnology and Biotechnology, SpringerReference, DOI 10.1007/978-3-319-04033-2_65-1 (2014).

  2. H. –J. Choi*, C. D. Montemagno*, Epidemiology-theory, research and practice, “Assessment of osmotic characteristics of influenza viruses” iConcept Press Ltd., ISBN 978-1-922227-33-1 (2014).    




  1. A. Kumar, C. D. Montemagno*, H. –J. Choi*,“Targeted Oral Vaccine Delivery System” Collaborative Conference on Materials Research (CCMR), June 28, 2017, Jeju, Korea (Invited). 

  2. A. Kumar, H. –J. Choi*, C. D. Montemagno*, “Targeted Oral Vaccine Delivery System” Collaborative Conference on Materials Research (CCMR), June 26, 2017, Jeju, Korea.  

  3. I. Rubino, H. –J. Choi*, "Engineered Oral Vaccine Delivery Systems" Alberta Virology Conference, June 1, 2017, Edmonton, Alberta, Canada.

  4. I. Rubino, H. –J. Choi*, "Universal and Recyclable Virus Deactivation System for Protection against Pathogenic Aerosols" Alberta Virology Conference, June 1, 2017, Edmonton, Alberta, Canada.

  5. C. Sun, B. Homayun, H. –J. Choi*, C. D. Montemagno*, "Low cost production of small intestine-targeted drug delivery systems" CSC 2017, May 30, 2017, Toronto, Ontario, Canada.

  6. I. Rubino, H. –J. Choi*, "Development of a Universal and Recyclable Virus Deactivation System for Protection against Airborne Transmissible Pathogenic Aerosols" MRS Spring Meeting, April 19, 2017, Phoenix, Arizona, USA.

  7. B. Homayun, A. Kumar, C. Sun, H. –J. Choi*, C. D. Montemagno*, “pH-sensing drug delivery system using anionic copolymer” MRS Winter Meeting, Nov 30, 2016, Boston, Massachusetts, USA.

  8. H. –J. Choi*, “Development of long-term stable, solid influenza vaccine formulations” Collaborative Conference on 3D & Materials Research (CC3DMR), June 16, 2015, Busan, Korea (Invited).

  9. H. –J. Choi*, A. Kumar, C. D. Montemagno*, “One-Stop Solution for Delivery of Unstable Oral Drugs” MRS Spring Meeting, April 8, 2015, San Francisco, California, USA.

  10. A. Kumar, H. –J. Choi*, C. D. Montemagno*, “Development of Oral Influenza Vaccines: One Step Closer” MRS Spring Meeting, April 8, 2015, San Francisco, California, USA.    


* Corresponding author   

Copyright - SEƎD Laboratory